|Articles|May 1, 2001

Cyclosporin-A improves management of SJS/TEN

Palm Beach, Fla. - Low-pulse cyclosporin-A is a promising treatment for Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), Sabra Sullivan, M.D., chief of dermatology, University of Mississippi (Jackson) Medical Center, reported the annual meeting of the Noah Worcester Dermatological Society.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Latest CME